These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 400821

  • 1. In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole.
    Shadomy S, Wagner G, Carver M.
    Antimicrob Agents Chemother; 1978 Mar; 13(3):412-5. PubMed ID: 400821
    [Abstract] [Full Text] [Related]

  • 2. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV, Sanders CC, Sanders W.
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD.
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [Abstract] [Full Text] [Related]

  • 4. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.
    Jones RN, Thornsberry C, Barry AL, Fuchs PC, Gavin TL, Gerlach EH.
    J Antibiot (Tokyo); 1977 Jul; 30(7):583-92. PubMed ID: 893227
    [Abstract] [Full Text] [Related]

  • 5. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA, Buck RE, Price KE, Leitner F.
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [Abstract] [Full Text] [Related]

  • 6. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG, Stilwell GA, Turck M.
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins.
    Aswapokee N, Aswapokee P, Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of resistance determinants to cefamandole and cefoxitin in Enterobacter cloacae strains.
    Vuye A.
    Microbios; 1983 Jul; 38(153-154):159-69. PubMed ID: 6606106
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL, Freundlich LF, Quraishi MA.
    Chemotherapy; 1979 Jul; 25(3):157-61. PubMed ID: 456076
    [Abstract] [Full Text] [Related]

  • 10. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
    Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S.
    Infection; 1983 Jul; 11(6):315-7. PubMed ID: 6321357
    [Abstract] [Full Text] [Related]

  • 11. Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.
    Beckwith DG, Jahre JA.
    J Clin Microbiol; 1980 Oct; 12(4):517-20. PubMed ID: 6968320
    [Abstract] [Full Text] [Related]

  • 12. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
    Weaver SS, LeBlanc BM, Bodey GP.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520
    [Abstract] [Full Text] [Related]

  • 13. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
    Gootz TD, Sanders CC, Goering RV.
    J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL, Lewis RP, Meyer RD.
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [Abstract] [Full Text] [Related]

  • 15. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC, Sanders WE.
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [Abstract] [Full Text] [Related]

  • 16. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I, Dickert H, Machka K.
    Infection; 1979 Jun; 7(5):231-6. PubMed ID: 389804
    [Abstract] [Full Text] [Related]

  • 17. In vivo inoculum effect and resistance selection with cefamandole and cefoxitin against Enterobacter cloacae in mice.
    Miller AK, Celozzi E, Pelak BA, Birnbaum J, Stapley EO.
    J Antimicrob Chemother; 1980 Nov; 6(6):804-6. PubMed ID: 7002900
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.
    de Girolami PC, Maher LA, Booth MT, St George DM.
    J Clin Microbiol; 1980 Oct; 12(4):546-9. PubMed ID: 6999021
    [Abstract] [Full Text] [Related]

  • 19. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)].
    Schröter G, Loch R.
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(3):317-23. PubMed ID: 44786
    [Abstract] [Full Text] [Related]

  • 20. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.
    Rylander M, Brorson JE, Johnsson J, Norrby R.
    Antimicrob Agents Chemother; 1979 Apr; 15(4):572-9. PubMed ID: 464588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.